IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Samsara BioCapital, LLC

Q4 2019 Holdings

Filed 2020-02-18 | 19 holdings | $208.7K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Intercept Pharmaceuticals Inc(ICPTUSD)COM45845P108$50.0K403,68824.0%
Springworks Therapeutics IncCOM85205L107$25.2K653,50212.1%
Allakos Inc(ALLKGUSD)COM01671P100$23.1K242,50511.1%
Odonate Therapeutics IncCOM676079106$17.0K522,6378.1%
Principia Biopharma Inc(PRNB)COM74257L108$16.8K306,7848.1%
Sutro BioPharma IncCOM869367102$12.4K1,125,5795.9%
Syros Pharmaceuticals IncCOM87184Q107$11.3K1,726,6035.4%
Atreca Inc(BCELUSD)COM04965G109$9.1K591,3684.4%
Aravive Inc(VSAREUR)COM03890D108$7.9K576,0663.8%
Hookipa Pharma IncCOM43906K100$6.5K530,2453.1%
Iveric Bio, Inc.(OPHTEUR)COM46583P102$6.0K700,0002.9%
Millendo Therapeutics IncCOM60040X103$4.8K715,2012.3%
Liquidia Technologies Inc(LQDA)COM53635D202$4.1K958,4662.0%
Bellus Health Inc(BLU)COM07987C204$3.7K488,8581.8%
Pieris Pharmaceuticals IncCOM720795103$2.5K704,2261.2%
Urovant Sciences LtdCOMG9381B108$2.4K157,4801.2%
KalVista Pharmaceuticals Inc(KALV)COM483497103$2.1K118,5001.0%
Sunesis Pharmaceuticals IncCOM867328700$2.0K5,938,2151.0%
Catabasis Pharmaceuticals Inc(CATBEUR)COM14875P206$1.8K300,0000.8%